- Home
- VVPR vs STRO Comparison
VVPR vs STRO Comparison
Compare VVPR & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- STRO
- Stock Information
- Founded
- VVPR 2014
- STRO 2003
- Country
- VVPR United Kingdom
- STRO United States
- Employees
- VVPR N/A
- STRO N/A
- Industry
- VVPR Power Generation
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VVPR Utilities
- STRO Health Care
- Exchange
- VVPR Nasdaq
- STRO Nasdaq
- Market Cap
- VVPR 62.7M
- STRO 69.1M
- IPO Year
- VVPR 2016
- STRO 2018
- Fundamental
- Price
- VVPR $6.33
- STRO $0.88
- Analyst Decision
- VVPR
- STRO Hold
- Analyst Count
- VVPR 0
- STRO 8
- Target Price
- VVPR N/A
- STRO $3.83
- AVG Volume (30 Days)
- VVPR 2.3M
- STRO 504.1K
- Earning Date
- VVPR 01-01-0001
- STRO 08-07-2025
- Dividend Yield
- VVPR N/A
- STRO N/A
- EPS Growth
- VVPR N/A
- STRO N/A
- EPS
- VVPR N/A
- STRO N/A
- Revenue
- VVPR $79,000.00
- STRO $104,473,000.00
- Revenue This Year
- VVPR N/A
- STRO N/A
- Revenue Next Year
- VVPR N/A
- STRO N/A
- P/E Ratio
- VVPR N/A
- STRO N/A
- Revenue Growth
- VVPR N/A
- STRO N/A
- 52 Week Low
- VVPR $0.62
- STRO $0.52
- 52 Week High
- VVPR $8.88
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- VVPR 60.71
- STRO 59.29
- Support Level
- VVPR $3.60
- STRO $0.76
- Resistance Level
- VVPR $6.98
- STRO $0.83
- Average True Range (ATR)
- VVPR 0.66
- STRO 0.06
- MACD
- VVPR 0.21
- STRO -0.00
- Stochastic Oscillator
- VVPR 80.77
- STRO 59.03
About VVPR VivoPower International PLC
Vivopower International PLC is a solar power company. It provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions, Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Electric Vehicles segment. Geographically its key revenue derives from the Netherlands.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.